In the beginning, Pfizer advertised that Science Will Win. Back in 2020, it sounded like all of Science would work together to overcome the pandemic. Fast forward to last week.
It looks like Science doesn’t want to play in the same sandbox anymore.
Moderna is going after Pfizer, suing them for vaccine patent infringement. When I heard that news, I immediately thought of two bullies on a playground. Bullies think they can do whatever they want. Sometimes they get what they want by force. Sometimes others assist them in their goal. Moderna and Pfizer, with the help from the US government, gained billions in a short amount of time. Countless mandates, encouraged by the government, helped those two companies stay ‘leader of the pack’ even today.
Pfizer’s Comirnaty brought in more than $36 billion in sales globally last year, and analysts expect it to bring in nearly $33 billion this year, according to FactSet.
Moderna Inc. booked $17.6 billion in revenue from its vaccine last year. Analysts project more than $21 billion in 2022.
Using similar tactics as last year, the government predicted “a pretty sizeable wave of infections” again this fall and winter. It would not be surprising if both of those pharmaceutical companies’ profits increased. That’ll happen when updated covid booster get approved.
Even though other manufacturers joined the warpseed-race to create and sell their own liability-free products, like the less popular Jansen and the now-available Novavax, the now-at-odds pharma giants garnered all the attention.
The Pfizer and Moderna vaccines deliver genetic instructions for the body to make copies of the spike protein. The lesser-used Johnson & Johnson option uses a cold virus to deliver those instructions.
When the Covid Era began, anytime vaccines were mentioned in the news, it seemed that Moderna and Pfizer were deemed the best, and only, choices.
Constant promotion of their products, even before they were made available, has kept the vaccine conversation going. Radio ads remain vague, as to exact ingredients used in the formula, but the message has always been clear – get the shot.
Get it now, and again, and again.
And now get it one more time. With a new formula. Which probably can help. But we’re not exactly sure yet.
“A bivalent vaccine will have some benefit for almost everybody who gets it,” Rishi Goel, an immunologist at the University of Pennsylvania, told me. “How much benefit that is, we’re still not exactly sure.”
That uncertainty, to me, is a red flag. So has been the getting around of what had been standard safety testing. The drive, though, to get vaccinated and boosted continues.
It’s all just been a bit odd to me. The massive push for fast-tracked vaccines. The belittling of those who chose not to get them. The ever-shady tactics. The constant moving of the goalposts. And the complete lack of logic.
I know this hasn’t been easy for a lot of people, including for my own family and friends. But I haven’t fallen for it. If you haven’t fallen for any of this either, stay the course. Bullies may be strong. It would be awesome if we can stay stronger.
Cathy Jameson is a Contributing Editor for Age of Autism.